MAPT and Alzheimer disease: Regarding clinical diagnosis, CSF and plasma measures of full-length and mid-region only fragments of tau do not appear to efficiently differentiate MCI and AD populations from unimpaired controls, whereas levels of N-terminal containing tau fragments can separate these populations20.